24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
| No Data For This Reporting Period. | |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
52.78% |
|
ANTIBODY AFFINITY MATURATION |
26.39% |
|
ALZHEIMERS |
20.83% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
20.96% |
|
ANTIBODY DYNAMICS SIMULATION |
13.98% |
|
IL 2 FORCE FIELD BENCHMARKING |
10.6% |
|
ANTIBODY DYNAMICS |
10.01% |
|
ANTIBODY AFFINITY MATURATION |
9.89% |
|
ALZHEIMERS |
9.18% |
|
IL 2 RECEPTOR DYNAMICS |
7.93% |
|
IL 2 DYNAMICS SIMULATIONS |
7.56% |
|
ENZYME DYNAMICS |
4.83% |
|
IL 2 MOLECULAR DYNAMICS |
1.55% |
|
IL2 RECEPTOR DYNAMICS |
1.13% |
|
STP6 SUGAR TRANSPORT |
.82% |
|
ANTIBODY MATURATION SIMULATION |
.6% |
|
SUCROSE TRANSPORT PLANTS |
.41% |
|
ATSTP10 SUCROSE TRANSPORT |
.24% |
|
PARKINSONS |
.18% |
|
MEMBRANE TRANSPORT |
.13% |